Giovanni Puglisi

Giovanni Puglisi

Auto-generated profile, based on publicly available information

Giovanni Puglisi

Laboratory of Drug Delivery Technology - Department of Drug Sciences, University of Catania, Catania, Italy

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2017 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
LCLucia Crascì
Lucia Crascì
Maria Rosaria LauroMaria Rosaria Lauro
Maria Rosaria Lauro
GPGiovanni Puglisi
Giovanni Puglisi
APAnnamaria Panico
Annamaria Panico
The diet polyphenols are a secondary metabolites of plants able to act on inflammation process. Their anti-inflammatory activity is articulated through several mechanisms that are related to their antioxidative and radical scavengers properties. Our work is focused on a novel approach to inflammatory disease management, based on anti-glycative and matrix metalloproteinases (MMPs) inhibition effects, as a connected phenomena. To better understand these correlation, polyphenols Structure-Activity Relationship (SAR) studies were also reported. The antioxidant polyphenols inhibit the AGEs at different levels of the glycation process in the following ways: (1) prevention of Amadori adduct oxidation; (2) trapping reactive dycarbonyl compounds; (3) attenuation of receptor for AGEs (RAGE) expression. Moreover, several flavonoids with radical scavenging property showed also MMPs inhibition interact directly with MMPs or indirectly via radical scavengers and AGEs reduction. The essential polyphenols features involved in these mechanisms are C2-C3 double bond and number and position of hydroxyl, glycosyl and O-methyl groups. These factors induce a change in molecular planarity interfering with the hydrogen bond formation, electron delocalization and metal ion chelation. In particular, C2-C3 double bond improve the antioxidant and MMPs inhibition, while the hydroxylation, glycosylation and methylation induce a positive and negative correlation, respectively.

19 September 2016 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
Carmelo PugliaCarmelo Puglia
Carmelo Puglia
Maria Rosaria LauroMaria Rosaria Lauro
Maria Rosaria Lauro
GTGiorgia Giusy Tirendi
Giorgia Giusy Tirendi
GFGiuseppina Emanuela Fassari
Giuseppina Emanuela Fassari
Claudia CarboneClaudia Carbone
Claudia Carbone
GPGiovanni Puglisi
Giovanni Puglisi
Introduction: Colloidal drug delivery systems (CDDSs) are innovative carriers that have been studied in pharmaceutical field from many years to overcome unfavorable physical and chemical features of synthetic drugs. Recently the use of CDDS as carriers for phytochemicals has seen an exponential increase which, in some cases, has led to the rediscovery of ancient and forgotten natural molecules. Area covered: This article focuses on the main features of CDDS, particularly micro- and nanoemulsions, vesicular carriers and micro- and nanoparticles, loaded with natural active compounds. A detailed review of the literature is presented, introducing the importance of these systems in terms of their capability to optimize the stability of phytochemicals, their absorption through biological membranes and their bioavailability. Expert opinion: The delivery of phytochemicals is problematic due to poor solubility, poor permeability, low bioavailability, instability in biological milieu and extensive first-pass metabolism. Global research efforts investigating nanotechnology have attempted to overcome these limitations rediscovering and, in some cases, ‘discovering ex novo’ unexpected virtues and benefits associated to these compounds. The ‘nanotechnological approach’ can definitely enhance the pharmacokinetics and therapeutic index of natural active compounds and improve their performance in therapy.

22 February 2017 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
ABAngela Bonaccorso
Angela Bonaccorso
Teresa MusumeciTeresa Musumeci
Teresa Musumeci
Claudia CarboneClaudia Carbone
Claudia Carbone
LVL. Vicari
L. Vicari
Maria Rosaria LauroMaria Rosaria Lauro
Maria Rosaria Lauro
GPG. Puglisi
G. Puglisi
The efficient design of nanocarriers is a major challenge and must be correlated with the route of administration. Intranasal route is studied for local, systemic or cerebral treatments. In order to develop nanocarriers with suitable properties for intranasal delivery, to achieve brain and to market the product, it is extremely important the simplification of the formulation in terms of raw materials. Surfactants and cryoprotectants are often added to improve structuration and/or storage of polymeric nanoparticles. PLGA-PEG nanocarriers were prepared by nanoprecipitation method evaluating the critical role of sucrose as surfactant-like and cryoprotectant, with the aim to obtain a simpler formulation compared to those proposed in other papers. Photon correlation spectroscopy and Turbiscan analysis show that sucrose is a useful excipient during the preparation process and it effectively cryoprotects nanoparticles. Among the investigated nanocarriers with different degree of PEG, PEGylated PLGA (5%) confers weak interaction between nanoparticles and mucin as demonstrated by thermal analysis and mucin particle method. Furthermore, in vitro biological studies on HT29, as epithelium cell line, does not show cytotoxicity effect for this nanocarrier at all texted concentrations. The selected nanosystem was also studied to load docetaxel, as model drug, and characterized by a technological point of view.

1 January 2015 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
Claudia CarboneClaudia Carbone
Claudia Carbone
Teresa MusumeciTeresa Musumeci
Teresa Musumeci
Maria Rosaria LauroMaria Rosaria Lauro
Maria Rosaria Lauro
GPG. Puglisi
G. Puglisi

14 November 2019 in Journal of Liposome Research
Verified
Journal Article
Closed access
Teresa MusumeciTeresa Musumeci
Teresa Musumeci
ABAngela Bonaccorso
Angela Bonaccorso
Federica De GaetanoFederica De Gaetano
Federica De Gaetano
Kim Lambertsen LarsenKim Lambertsen Larsen
Kim Lambertsen Larsen
Rosario PignatelloRosario Pignatello
Rosario Pignatello
CVC. A. Ventura
C. A. Ventura
In this paper, two medusa-like ACyDs, modified at the primary rim bearing four (ACyD4) and eight carbons (ACyD8) acyl chain length, and one bouquet-like CyD, modified at primary side with thiohexyl and at secondary one with oligoethylene moiety (SC6OH), were investigated for their ability to assemble in nanostructures or to form hybrid dipalmitoylphosphatidylcholine (DPPC)/ACyDs systems. The lipophilicity of these molecules and the different preparation methods used in this study (thin layer evaporation and nanoprecipitation method) significantly affect the aggregation behaviour in aqueous medium. Except for the shortest medusa-like ACyD4, the other ACyDs formed stable nanoaggregates for at least 45 days. The effect of ACyDs on the thermotropic behaviour of DPPC liposomes was also studied by differential scanning calorimetry analysis, thus elucidating their interaction with liposomes to afford hybrid liposome/ACyDs systems. The medusa-like ACyD4 cannot be used to realize nanosystems because it quickly aggregates or it induces a complete destabilization of the liposomes. At the highest concentration investigated (0.01 molar fraction), both ACyD8 and SC6OH interacted with DPPC liposomes, forming ACyD/DPPC or SC6OH/DPPC hybrid vesicular carriers.

1 January 2001 in Journal of Drug Targeting
Verified
Journal Article
Closed access
PDF file
Cinzia Anna VenturaCinzia Anna Ventura
Cinzia Anna Ventura
Massimo FrestaMassimo Fresta
Massimo Fresta
Donatella PaolinoDonatella Paolino
Donatella Paolino
SPSonia Pedotti
Sonia Pedotti
ACA. Corsaro
A. Corsaro
GPG. Puglisi
G. Puglisi
The effects of different concentrations of β-cyclodextrin (β-CyD), hydroxypropyl-β-cyclodextrin (HP-β-CyD) and 2,6-di-O-methyl-β-cyclodextrin (DM-β-CyD) on percutaneous absorption of papaverine hydrochloride (PAP) were investigated. Abdominal rat skin mounted in Franz cells was used for in vitro experiments. To evaluate CyD interaction with a bilayer structure model, dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and DPPC-Chol (8:2 mole ratio) vesicles were used. CyD vesicle interaction was evaluated by differential scanning calorimetry. Permeation through rat skin and calorimetric experiments demonstrated that at low concentrations DM-β-CyD shows higher enhancer activity as a possible result of a perturbing action on the skin by a complexation of its lipid components, but at higher concentrations HP-β-CyD is the most effective. By considering that HP-β-CyD presents a very moderate destabilizing action on the skin, we conclude that a 10% aqueous solution of this macrocycle appears to be the most suitable transdermal absorption enhancer for PAP.